174 related articles for article (PubMed ID: 21993694)
1. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Heleniak Z; Bryl E; Witkowski JM
J Clin Immunol; 2012 Feb; 32(1):189-200. PubMed ID: 21993694
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
Meier P; Dayer E; Ronco P; Blanc E
Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.
Costa E; Lima M; Alves JM; Rocha S; Rocha-Pereira P; Castro E; Miranda V; do SF; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
J Clin Immunol; 2008 May; 28(3):268-75. PubMed ID: 18205031
[TBL] [Abstract][Full Text] [Related]
5. One-year immunological evaluation of chronic hemodialysis in end-stage renal disease patients.
Meier P; von Fliedner V; Markert M; van Melle G; Deppisch R; Wauters JP
Blood Purif; 2000; 18(2):128-37. PubMed ID: 10838472
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin.
Ueki Y; Nagata M; Miyake S; Tominaga Y
J Clin Immunol; 1993 Jul; 13(4):279-87. PubMed ID: 7901232
[TBL] [Abstract][Full Text] [Related]
7. Altered CD46-mediated T cell co-stimulation in haemodialysis patients.
Brinkkoetter PT; Marinaki S; Gottmann U; Fleckenstein S; Stump C; Van Der Woude FJ; Braun C; Yard BA
Clin Exp Immunol; 2005 Mar; 139(3):534-41. PubMed ID: 15730400
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.
Borges A; Borges M; Fernandes J; Nascimento H; Sameiro-Faria M; Miranda V; Reis F; Belo L; Costa E; Santos-Silva A
Ren Fail; 2011; 33(2):138-43. PubMed ID: 21332334
[TBL] [Abstract][Full Text] [Related]
9. Influence of hemodialysis on circulating CD4(low)CD25 (high) regulatory T cells in end-stage renal disease patients.
Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Bryl E; Witkowski JM
Inflamm Res; 2014 Feb; 63(2):99-103. PubMed ID: 24189710
[TBL] [Abstract][Full Text] [Related]
10. The influence of recombinant human erythropoietin on apoptosis and cytokine production of CD4+ lymphocytes from hemodialyzed patients.
Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Daca A; Bryl E; Witkowski JM
J Clin Immunol; 2013 Apr; 33(3):661-5. PubMed ID: 23180360
[TBL] [Abstract][Full Text] [Related]
11. T-cell function, T-cell phenotype and its role in responsiveness to recombinant human erythropoietin in hemodialysis patients.
Abdalla M; Yassein S; Darwish KH
Egypt J Immunol; 2010; 17(2):67-80. PubMed ID: 23082488
[TBL] [Abstract][Full Text] [Related]
12. T cell subpopulations and cytokine levels in hemodialysis patients.
Lisowska KA; Storoniak H; Dębska-Ślizień A
Hum Immunol; 2022 Feb; 83(2):134-143. PubMed ID: 34802797
[TBL] [Abstract][Full Text] [Related]
13. The influence of a single hemodialysis procedure on human T lymphocytes.
Lisowska KA; Pindel M; Pietruczuk K; Kuźmiuk-Glembin I; Storoniak H; Dębska-Ślizień A; Witkowski JM
Sci Rep; 2019 Mar; 9(1):5041. PubMed ID: 30911040
[TBL] [Abstract][Full Text] [Related]
14. T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?
Heron M; Claessen AM; Grutters JC; van den Bosch JM
Clin Exp Immunol; 2010 May; 160(2):256-65. PubMed ID: 20030671
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
17. The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality.
Xiaoyan J; Rongyi C; Xuesen C; Jianzhou Z; Jun J; Xiaoqiang D; Xiaofang Y
BMC Nephrol; 2019 Aug; 20(1):301. PubMed ID: 31383007
[TBL] [Abstract][Full Text] [Related]
18. No effect of transfusion transmitted virus viremia on the distribution and activation of peripheral lymphocytes in hemodialyzed patients.
Fodor B; Ladányi E; Aleksza M; Takács M; Lakos G; Arkossy O; Koós A; Nagy A; Széll J; Klenk N; Sárváry E; Sipka S
Nephron; 2002 Dec; 92(4):933-7. PubMed ID: 12399644
[TBL] [Abstract][Full Text] [Related]
19. Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised.
Baron M; Belo R; Cathelin D; Moreira-Teixeira L; Cartery C; Rondeau E; Mesnard L; Leite-de-Moraes M
PLoS One; 2014; 9(8):e105422. PubMed ID: 25144742
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
